DE69840433D1 - Fasciola hepatica impfstoffe - Google Patents

Fasciola hepatica impfstoffe

Info

Publication number
DE69840433D1
DE69840433D1 DE69840433T DE69840433T DE69840433D1 DE 69840433 D1 DE69840433 D1 DE 69840433D1 DE 69840433 T DE69840433 T DE 69840433T DE 69840433 T DE69840433 T DE 69840433T DE 69840433 D1 DE69840433 D1 DE 69840433D1
Authority
DE
Germany
Prior art keywords
vaccines
fasciola hepatica
antibodies
hepatica
fasciola
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69840433T
Other languages
English (en)
Inventor
Milligen Florine Johanna Van
Johannes Bernardus Cornelissen
Bernard Adri Bokhout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Dienst Landbouwkundig Onderzoek DLO
Original Assignee
Stichting Dienst Landbouwkundig Onderzoek DLO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Dienst Landbouwkundig Onderzoek DLO filed Critical Stichting Dienst Landbouwkundig Onderzoek DLO
Application granted granted Critical
Publication of DE69840433D1 publication Critical patent/DE69840433D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/43547—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from trematodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • General Physics & Mathematics (AREA)
DE69840433T 1997-03-11 1998-03-11 Fasciola hepatica impfstoffe Expired - Fee Related DE69840433D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200730 1997-03-11
PCT/NL1998/000146 WO1998040497A2 (en) 1997-03-11 1998-03-11 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method

Publications (1)

Publication Number Publication Date
DE69840433D1 true DE69840433D1 (de) 2009-02-26

Family

ID=8228093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69840433T Expired - Fee Related DE69840433D1 (de) 1997-03-11 1998-03-11 Fasciola hepatica impfstoffe

Country Status (11)

Country Link
US (5) US6551594B1 (de)
EP (1) EP0966537B1 (de)
JP (1) JP4321881B2 (de)
AT (1) ATE420184T1 (de)
AU (1) AU6424298A (de)
BR (1) BR9808251B1 (de)
CA (1) CA2284110C (de)
DE (1) DE69840433D1 (de)
NZ (1) NZ337697A (de)
TR (1) TR199902609T2 (de)
WO (1) WO1998040497A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199902609T2 (xx) 1997-03-11 2000-06-21 Stichting Dienst Landbouwkundig Onderzoek Parazitlere kar�� koruyucu ba����kl���n �l��lmesi i�in y�ntem olarak bir eks vivo hayvan ya da y�kleme modeli ve bahsedilen y�ntemde koruyucu oldu�u g�sterilmi� a��lar.
ES2184569B1 (es) * 2000-08-07 2004-02-01 Inst Nac Investigacion Inia Empleo de los productos de excrecion secrecion de fasciola hepatica en la elaboracion de un medicamento para el tratamiento de enfermedades hepaticas y/o para evitar o reducir el rechazo al transplante hepatico.
US20040091914A1 (en) * 2002-08-02 2004-05-13 Sysmex Corporation Gene assay method for predicting glaucoma onset risk
WO2007066313A2 (en) 2005-12-05 2007-06-14 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Compositions and methods for modulating an immune response
US10441642B2 (en) 2015-03-18 2019-10-15 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Immunogenic compositions and vaccines for preventing or treating filarial disease
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
EP0666919B1 (de) * 1992-10-21 2003-05-14 John Pius Dalton Thiolprotease enthaltender impfstoff
EP0647138A4 (de) * 1993-02-05 1996-03-06 Daratech Pty Ltd Polypeptide erhältlich aus fasciola spezien, und vakzine, therapieverfahren und dna sequenzen diese peptide kodierend.
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
TR199902609T2 (xx) 1997-03-11 2000-06-21 Stichting Dienst Landbouwkundig Onderzoek Parazitlere kar�� koruyucu ba����kl���n �l��lmesi i�in y�ntem olarak bir eks vivo hayvan ya da y�kleme modeli ve bahsedilen y�ntemde koruyucu oldu�u g�sterilmi� a��lar.

Also Published As

Publication number Publication date
TR199902609T2 (xx) 2000-06-21
WO1998040497A3 (en) 1998-12-10
AU6424298A (en) 1998-09-29
US20100285049A1 (en) 2010-11-11
JP2001527391A (ja) 2001-12-25
US20030224007A1 (en) 2003-12-04
US20080138358A1 (en) 2008-06-12
CA2284110A1 (en) 1998-09-17
WO1998040497A2 (en) 1998-09-17
US6551594B1 (en) 2003-04-22
BR9808251A (pt) 2000-05-16
US7744907B2 (en) 2010-06-29
JP4321881B2 (ja) 2009-08-26
ATE420184T1 (de) 2009-01-15
US8507658B2 (en) 2013-08-13
CA2284110C (en) 2012-08-28
EP0966537B1 (de) 2009-01-07
NZ337697A (en) 2001-06-29
US8088909B2 (en) 2012-01-03
US20120107342A1 (en) 2012-05-03
EP0966537A2 (de) 1999-12-29
BR9808251B1 (pt) 2012-09-04

Similar Documents

Publication Publication Date Title
EA199900325A1 (ru) Форма d дигидрата оланзапина
DK0539477T3 (da) Fremgangsmåde til forstærkning af emissionssignalet af en luminescerende forbindelse
NO2013009I1 (no) Alipogen tiparvovec
DK0710253T3 (da) Antistoffer, der er specifikke mod human prostatakirtel-kallikrein
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
ATE234091T1 (de) Thrombin inhibitoren
ATE420184T1 (de) Fasciola hepatica impfstoffe
IT8319052A0 (it) Impianto per la messa in prova di un pozzo e procedimento per la sua messa in opera.
FI843681A0 (fi) Polyhydroxibenzoesyraderivat.
DK157939C (da) Reagens til optisk bestemmelse af blodkoagulationsforholdet
DK0744027T3 (da) Anvendelse af fremgangsmåder til identifikation af hydrofile signaloligopeptider
NO823508L (no) Reagens bestemmelse av ristocetin-kofaktoren (willebrand-faktor).
DE68923597D1 (de) Eingangsstufen-Vorrichtung eines optischen Empfängers.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
DE69003295D1 (de) Ringförmige Dichtungen.
FI843436A (fi) Foerfarande foer framstaellning av 2-oxo-karbonsyrareduktas och dess anvaendning.
SE8803182L (sv) Snabbloesbar koppling
SE8700350L (sv) Telefonapparat
ES2128413T3 (es) Composiciones adhesivas sensibles a la presion elastomericas que muestran un buen comportamiento de corte.
NO905003D0 (no) Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft.
DK177791D0 (da) Tensidfrie, faste enzympraeparater omfattende protease som virksomt enzym
IT8421095A0 (it) Amplificatore pneumatico di accoppiamento.
DK153566C (da) Vaskemiddelblanding baseret paa alkalimetalperborat, en aktivator til nedbrydning af perboratet og et proteolytisk enzym opnaaet ud fra en bacillus-stamme
DE69925736D1 (de) Lupus antikoagulant-antikörper gegen die f1 region von prothrombin
IT1267410B1 (it) Procedimento per la determinazione di biomolecole mediante un sistema di amplificazione enzimatica.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee